About Apteka
ABOUT
Easy does it
Apteka is a health policy and reimbursement consulting firm backed by over 20 years of experience. It was born out of the belief that there are more nimble and easy ways to get to solutions that move the needle in this space.
We do this by having the knowledge necessary to break down the topics so that they are easy to understand and, more importantly, we work together to determine what needs to be done to shape the environment. We partner with our clients to understand their priorities and challenges, knowing that each organization and product is unique.
All of this lights us up. We find joy in digging through final rules trying to find the answer to questions or reading the 4:15 pm newly released proposed regulation. We like talking to people about all of this and making sense of policy and want our clients to like working with us too.
And why the name? Apteka means pharmacy in Polish (and Russian) – our first and third languages.
Jennifer Snow
Founder/Managing Director
Jennifer Snow, MPH, is a healthcare professional with over 20 years of experience in policy and reimbursement with a focus on pharmaceuticals.
As the Founder of Apteka, she advises clients on healthcare policy and market trends on the federal and state level. She is a subject matter expert on many topics including the Inflation Reduction Act, the Affordable Care Act, 340B, supply chain dynamics, pharmacy benefit managers and federal health programs, particularly the Medicare Prescription Drug Benefit (Part D). Jennifer has presented nationally for health plan, payer, patient and pharmaceutical audiences and has experience in various therapeutic areas including cardiovascular, respiratory, mental health, diabetes, oncology and rheumatoid arthritis.
Prior to founding Apteka, Jennifer was a Vice President of Market Economics at AmerisourceBergen. There she conducted analysis and distilled key trends for internal and external stakeholders with a focus on the Inflation Reduction Act, 340B and biosimilars. She also served as Vice President of the Reimbursement Policy Insights group at Xcenda, AmerisourceBergen’s consulting division. At Xcenda, Jennifer served as a thought leader and led the organization’s consulting work in policy and reimbursement space working with dozens of large and small biopharmaceutical organizations, patient groups and industry associations. Earlier, Jennifer was part of AstraZeneca’s executive branch advocacy team and worked closely with Managed Markets, brand teams and Medical Affairs. Jennifer also worked for the Centers for Medicare & Medicaid Services on the Essential Health Benefit as well as Avalere Health and Stanford University. During her tenure at Stanford, she implemented both a consumer-driven health plan and a pharmacy benefit manager program.
Jennifer holds an M.P.H. from the University of North Carolina-Chapel Hill and a B.S. in Russian from Georgetown University